Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1450 participants
OBSERVATIONAL
2021-08-01
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
International Multicentre Prevalence Study on Sepsis
NCT01943747
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249
Evaluation of Plasma Angiotensin II and Angiotensin II Receptor Levels in Patients With Sepsis and Septic Shock: a Prospective Observational Study.
NCT04716842
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Sepsis Alliance
UNKNOWN
European Society of Anaesthesiology and Intensive Care
OTHER
European Society for Emergency Medicine (EUSEM) Research Network
NETWORK
European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group
UNKNOWN
European Society of Intensive Care Medicine
OTHER
Sepsisdialog, Germany
UNKNOWN
European Shock Society
UNKNOWN
Becton, Dickinson and Company
INDUSTRY
University Medicine Greifswald
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christian S. Scheer, MD
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian S Scheer
Role: PRINCIPAL_INVESTIGATOR
Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany
Adam Linder
Role: PRINCIPAL_INVESTIGATOR
European Sepsis Alliance
Daniela Filipescu
Role: PRINCIPAL_INVESTIGATOR
European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care
Evangelos Giamarellos-Bourboulis
Role: PRINCIPAL_INVESTIGATOR
European Sepsis Alliance, European Shock Society
Evgeny Idelevich
Role: PRINCIPAL_INVESTIGATOR
ESCMID/Study Group for Bloodstream Infections, Endocarditis and Sepsis
Konrad Reinhart
Role: PRINCIPAL_INVESTIGATOR
Global Sepsis Alliance
Matthias Gründling
Role: PRINCIPAL_INVESTIGATOR
Quality management project Sepsisdialog
Ricard Ferrer
Role: PRINCIPAL_INVESTIGATOR
European Society of Intensive Care Medicine
Said Laribi
Role: PRINCIPAL_INVESTIGATOR
European Society for Emergency Medicine (EUSEM) Research Network
Manu Malbrain
Role: PRINCIPAL_INVESTIGATOR
International Fluid Academy
Gabriella Bottari
Role: PRINCIPAL_INVESTIGATOR
European Society of Paediatric and Neonatal Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emergency Department Antwerp University Hospital
Edegem, , Belgium
Department of Anesthesiology and Intensive Care Medicine University Hospital of Ostrava
Ostrava-Poruba, , Czechia
Department of Emergency Medicine University of Southern Denmark
Odense, , Denmark
Perioperative, Intensive Care and Pain Medicine Helsinki University Hospital
Helsinki, , Finland
Hopital Raymond Poncare Service de Reanimation Medicale
Garches, , France
University Medicine Greifswald
Greifswald, , Germany
4th Department of Internal Medicine ATTIKON University Hospital
Athens, , Greece
National Institute for Antibiotic Resistance & Infection Control, Ministry of Health
Tel Aviv, , Israel
Ospedale Niguarda Ca' Granda Milano
Milan, , Italy
State University of Medicine and Pharmaceutics "Nicolae Testemiţanu"
Chisinau, , Moldova
University Medical Center Groningen
Groningen, , Netherlands
St Olavs hospital
Trondheim, , Norway
Department of Anaesthesiology and Intensive Therapy Wroclaw Medical University
Wroclaw, , Poland
Universidade do Porto Faculdade de Medicina: Porto
Porto, , Portugal
"Prof CC Iliescu" Emergency Institute for Cardiovascular Diseases, Bucharest
Bucharest, , Romania
Vladimir L. Vanevskii Department of Anaesthesiology and Reanimatology, North-Western State Medical University named after Ilya I. Mechnikov
Saint Petersburg, , Russia
Corporació Sanitària Parc Taulí · critical care center, sabadell hospital, Corporació Sanitaria Universitaria Parc Tauli
Sabadell, , Spain
Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University
Lund, , Sweden
Hacettepe University, Department of Internal Medicine Sihhiye, Ankara
Ankara, , Turkey (Türkiye)
King's College London, Guy's and St Thomas' Foundation Hospital, Department of Critical Care, London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ceccato A, Scheer CS, Ferrer R, Martinez ML, Cistero B, Yebenes JC, Trenado J, Lorencio C, Linder A, Filipescu D, Idelevich EA, Giamarellos-Bourboulis EJ, Artigas A; European Sepsis Care Study Group. Regional sepsis care in Catalonia: comparative insights from a secondary analysis of the European Sepsis Care Survey. Crit Care. 2025 Aug 19;29(1):367. doi: 10.1186/s13054-025-05507-3. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BB 124/21
Identifier Type: OTHER
Identifier Source: secondary_id
ESA_Survey01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.